» Articles » PMID: 31179276

Use of Nanoparticles in Tissue Engineering and Regenerative Medicine

Overview
Date 2019 Jun 11
PMID 31179276
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in nanoparticle (NP) production and demand for control over nanoscale systems have had significant impact on tissue engineering and regenerative medicine (TERM). NPs with low toxicity, contrasting agent properties, tailorable characteristics, targeted/stimuli-response delivery potential, and precise control over behavior (via external stimuli such as magnetic fields) have made it possible their use for improving engineered tissues and overcoming obstacles in TERM. Functional tissue and organ replacements require a high degree of spatial and temporal control over the biological events and also their real-time monitoring. Presentation and local delivery of bioactive (growth factors, chemokines, inhibitors, cytokines, genes etc.) and contrast agents in a controlled manner are important implements to exert control over and monitor the engineered tissues. This need resulted in utilization of NP based systems in tissue engineering scaffolds for delivery of multiple growth factors, for providing contrast for imaging and also for controlling properties of the scaffolds. Depending on the application, materials, as polymers, metals, ceramics and their different composites can be utilized for production of NPs. In this review, we will cover the use of NP systems in TERM and also provide an outlook for future potential use of such systems.

Citing Articles

Lantana camara plant extract catalyzed biosynthesis of graphene-metal nanocomposites with potential cytotoxic activities.

Khan K, Rehman M, Hameed M, Hayat K, Saeed F, Afzaal M PLoS One. 2025; 20(3):e0314850.

PMID: 40073028 PMC: 11902251. DOI: 10.1371/journal.pone.0314850.


An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography Applications.

Sebatana R, Kudzai K, Magura A, Mdlophane A, Zeevaart J, Sathekge M Pharmaceutics. 2025; 17(2).

PMID: 40006607 PMC: 11858949. DOI: 10.3390/pharmaceutics17020240.


Ionomeric Nanofibers: A Versatile Platform for Advanced Functional Materials.

Poddar M, Chang Y, Chiu F Polymers (Basel). 2025; 16(24.

PMID: 39771415 PMC: 11679054. DOI: 10.3390/polym16243564.


Nanotherapeutic and Nano-Bio Interface for Regeneration and Healing.

Kumar R, Igwegbe C, Khandel S Biomedicines. 2025; 12(12.

PMID: 39767834 PMC: 11673698. DOI: 10.3390/biomedicines12122927.


Progress in the Application of Multifunctional Composite Hydrogels in Promoting Tissue Repair.

Hui Y, Zheng X, Zheng Z, Wu C, Hao Y, Zhou B ACS Omega. 2024; 9(49):47964-47975.

PMID: 39676986 PMC: 11635483. DOI: 10.1021/acsomega.4c08103.


References
1.
Salata O . Applications of nanoparticles in biology and medicine. J Nanobiotechnology. 2004; 2(1):3. PMC: 419715. DOI: 10.1186/1477-3155-2-3. View

2.
Vieira S, Vial S, Reis R, Oliveira J . Nanoparticles for bone tissue engineering. Biotechnol Prog. 2017; 33(3):590-611. DOI: 10.1002/btpr.2469. View

3.
Yao C, Zhu J, Xie A, Shen Y, Li H, Zheng B . Graphene oxide and creatine phosphate disodium dual template-directed synthesis of GO/hydroxyapatite and its application in drug delivery. Mater Sci Eng C Mater Biol Appl. 2017; 73:709-715. DOI: 10.1016/j.msec.2016.11.083. View

4.
Savla R, Minko T . Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value. Adv Drug Deliv Rev. 2016; 113:122-140. DOI: 10.1016/j.addr.2016.06.016. View

5.
Kunath S, Panagiotopoulou M, Maximilien J, Marchyk N, Sanger J, Haupt K . Cell and Tissue Imaging with Molecularly Imprinted Polymers as Plastic Antibody Mimics. Adv Healthc Mater. 2015; 4(9):1322-6. DOI: 10.1002/adhm.201500145. View